Literature DB >> 11504585

High strength stimulation of the vagus nerve in awake humans: a lack of cardiorespiratory effects.

A P Binks1, D Paydarfar, S C Schachter, A Guz, R B Banzett.   

Abstract

UNLABELLED: Vagus nerve stimulation is used to reduce the frequency and intensity of seizures in patients with epilepsy. In the present study four such patients were studied while awake. We analyzed the physiological responses to vagus nerve stimulation over a broad range of tolerable stimulus parameters to identify vagal A-fiber threshold and to induce respiratory responses typical of C-fiber activation. A-fiber threshold was determined by increasing stimulation current until laryngeal motor A-fibers were excited (frequency=30 Hz). With A-fiber threshold established, C-fiber excitation was attempted with physiologically appropriate stimulus parameters (low frequency and high amplitude).
RESULTS: A-fiber thresholds were established in all patients, threshold currents ranged between 0.5 and 1.5 mA. Stimulation at lower frequency (2-10 Hz) and higher amplitudes (2.75-3.75 mA) did not produce cardiorespiratory effects consistent with C-fiber activation. It is possible that such effects were not observed because vagal C-fibers were not excited, because C-fiber effects were masked by the 'wakeful drive' to breathe, or because epilepsy or the associated therapy had altered central processing of the vagal afferent inputs.

Entities:  

Mesh:

Year:  2001        PMID: 11504585     DOI: 10.1016/s0034-5687(01)00252-3

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  10 in total

Review 1.  Therapeutic effects of vagus nerve stimulation in epilepsy and implications for sudden unexpected death in epilepsy.

Authors:  Steven C Schachter
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

2.  Sympathetic nerve fibers in human cervical and thoracic vagus nerves.

Authors:  Atsuko Seki; Hunter R Green; Thomas D Lee; LongSheng Hong; Jian Tan; Harry V Vinters; Peng-Sheng Chen; Michael C Fishbein
Journal:  Heart Rhythm       Date:  2014-04-24       Impact factor: 6.343

3.  Cardiorespiratory effects induced by vagus nerve stimulation in epileptic children.

Authors:  Mickael Pruvost; Boubker Zaaimi; Reinhard Grebe; Fabrice Wallois; Patrick Berquin; Volker Perlitz
Journal:  Med Biol Eng Comput       Date:  2006-03-22       Impact factor: 2.602

4.  Effects of Intraoperative Vagal Nerve Stimulation on the Gastrointestinal Microbiome in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Megan M Haney; Aaron C Ericsson; Teresa E Lever
Journal:  Comp Med       Date:  2018-11-13       Impact factor: 0.982

Review 5.  The parasympathetic nervous system in the quest for stroke therapeutics.

Authors:  Cletus Cheyuo; Asha Jacob; Rongqian Wu; Mian Zhou; Gene F Coppa; Ping Wang
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-02       Impact factor: 6.200

6.  Can we predict the response in the treatment of epilepsy with vagus nerve stimulation?

Authors:  A Arcos; L Romero; M Gelabert; A Prieto; J Pardo; X Rodriguez Osorio; M A Arráez
Journal:  Neurosurg Rev       Date:  2014-05-18       Impact factor: 3.042

7.  Low voltage vagal nerve stimulation reduces bronchoconstriction in guinea pigs through catecholamine release.

Authors:  Thomas J Hoffmann; Bruce J Simon; Yi Zhang; Charles W Emala
Journal:  Neuromodulation       Date:  2012-05-02

8.  Transvenous vagus nerve stimulation does not modulate the innate immune response during experimental human endotoxemia: a randomized controlled study.

Authors:  Matthijs Kox; Lucas T van Eijk; Tim Verhaak; Tim Frenzel; Harmke D Kiers; Jelle Gerretsen; Johannes G van der Hoeven; Lilian Kornet; Avram Scheiner; Peter Pickkers
Journal:  Arthritis Res Ther       Date:  2015-06-07       Impact factor: 5.156

9.  Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.

Authors:  Mario Cazzola; Luigino Calzetta; Francesco Facciolo; Paola Rogliani; Maria Gabriella Matera
Journal:  Respir Res       Date:  2017-01-24

10.  Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.

Authors:  Mario Cazzola; Luigino Calzetta; Ermanno Puxeddu; Josuel Ora; Francesco Facciolo; Paola Rogliani; Maria Gabriella Matera
Journal:  Respir Res       Date:  2016-06-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.